Exploring the Biosynthetic Potential of Tistrella Species for Producing Didemnin Antitumor Agents
ACS Chemical Biology · 2024
DOI: 10.1021/acschembio.4c00384 ↗At a glance
Journal article in ACS Chemical Biology, 2024. Written by Haili Zhang and 7 co-authors. Institution: Institute of Chemical Biology, Shenzhen Bay Laboratory, Shenzhen 518132, China. Major MEDLINE topics: Antineoplastic Agents, Depsipeptides. Cited 5 times so far (Crossref); 30 references. Funded by: Shenzhen Bay Laboratory, Basic and Applied Basic Research Foundation of Guangdong Province, Guangdong Provincial Pearl River Talents Program.
Abstract (original language)
Didemnins are a class of cyclic depsipeptides derived from sea tunicates that exhibit potent anticancer, antiviral, and immunosuppressive properties. Although certain Tistrella species can produce didemnins, their complete biosynthetic potential remains largely unexplored. In this study, we utilize feature-based molecular networking to analyze the metabolomics of Tistrella mobilis and Tistrella bauzanensis, focusing on the production of didemnin natural products. In addition to didemnin B, we identify nordidemnin B and [hysp2]didemnin B, as well as several minor didemnin analogs. Heterologous expression of the didemnin biosynthetic gene cluster in a Streptomyces host results in the production of only didemnin B and nordidemnin B in limited quantities. Isotope-labeling studies reveal that the substrate promiscuity of the adenylation domains during biosynthesis leads to the accumulation of nordidemnin B and [hysp2]didemnin B. Additionally, precursor-directed biosynthesis is applied to generate eight novel didemnin derivatives by supplementing the culture with structurally related amino acids. Furthermore, we increased the titers of nordidemnin B and [hysp2]didemnin B by supplementing the fermentation medium with l-valine and l-isoleucine, respectively. Finally, both compounds undergo side-chain oxidation to enhance their biological activity, with their anticancer properties found to be as potent as plitidepsin.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Institute of Chemical Biology, Shenzhen Bay Laboratory, Shenzhen 518132, China.
- College of Pharmacy, Guangxi Medical University, Nanning 530021, China.
- Department of Chemistry and Shenzhen Grubbs Institute, Southern University of Science and Technology, Shenzhen 518000, China.
- Department of Chemistry and The Swire Institute of Marine Science, The University of Hong Kong, Pokfulam Road, Hong Kong, China.
- Institute of Infectious Diseases, Shenzhen Bay Laboratory, Shenzhen 518132, China.
ORCID profiles: Xiaoyu Tang
Funding
- Shenzhen Bay Laboratory
- Basic and Applied Basic Research Foundation of Guangdong Province
- Guangdong Provincial Pearl River Talents Program
- National Natural Science Foundation of China
Cite
APA
Zhang, H., Huang, S., Zou, X., Shi, W., Liang, M., Lin, Y., Zheng, M., & Tang, X. (2024). Exploring the Biosynthetic Potential of Tistrella Species for Producing Didemnin Antitumor Agents. ACS Chemical Biology. https://doi.org/10.1021/acschembio.4c00384
Vancouver
Zhang H, Huang S, Zou X, Shi W, Liang M, Lin Y, et al. Exploring the Biosynthetic Potential of Tistrella Species for Producing Didemnin Antitumor Agents. ACS Chemical Biology. 2024. doi:10.1021/acschembio.4c00384
BibTeX
@article{Zhang2024,
author = {Zhang, Haili and Huang, Shipeng and Zou, Xiaolin and Shi, Wenguang and Liang, Mengdi and Lin, Yang and Zheng, Min and Tang, Xiaoyu},
title = {Exploring the Biosynthetic Potential of Tistrella Species for Producing Didemnin Antitumor Agents},
journal = {ACS Chemical Biology},
year = {2024},
doi = {10.1021/acschembio.4c00384}
}
EUVIMED